CV NEWS FEED // The Wall Street Journal, and other media has announced that the Supreme Court decided on Monday to hear the Biden administration’s challenge to Tennessee’s law prohibiting ‘gender transition care.’
The Justice Department contends that the Tennessee law infringes on the Constitution’s equal protection clause, arguing that the law discriminates by prohibiting medical treatments exclusively for gender dysphoria while allowing the same treatments for other conditions, such as precocious puberty.
A federal appeals court in Cincinnati dismissed that argument, with Chief Judge Jeffrey Sutton of the Sixth U.S. Circuit Court of Appeals writing, “The unsettled, developing, in truth still experimental, nature of treatments in this area surely permits more than one policy approach, and the Constitution does not favor one over the other.”
Tennessee is just one of many states that have banned or restricted ‘gender-affirming’ medication, joining South Carolina and over 23 other states amidst the growing unpopularity of allowing ‘gender-affirming’ medication for minors.
The case will be argued in the court’s upcoming term starting in October. This litigation arises at a time when transgender issues have taken center stage in state legislatures nationwide, and positions the justices at the center of a national debate on gender ideology.
The post Supreme Court to hear Biden’s challenge to Tennessee law prohibiting ‘gender transition’ medication for minors appeared first on CatholicVote org.
Click this link for the original source of this article.
Author: Rachel Quackenbush
This content is courtesy of, and owned and copyrighted by, https://catholicvote.org and its author. This content is made available by use of the public RSS feed offered by the host site and is used for educational purposes only. If you are the author or represent the host site and would like this content removed now and in the future, please contact USSANews.com using the email address in the Contact page found in the website menu.